良性病变子宫切除术后盆腔恶性肿瘤的临床特征

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (977 KB) HTML (0 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To analyze the clinical characteristics of malignant pelvic tumors after hysterectomy for benign lesions. Methods A total of 72 patients who underwent total or subtotal hysterectomy due to benign uterine or adrenal lesions were collected from Beijing Obstetrics and Gynecology Hospital affiliated to Capital Medical University from January 2013 to June 2022. According to pathological types of pelvic masses after hysterectomy, they were divided into benign disease group (49 cases) and malignant tumor group (23 cases). The clinical features and risk factors were analyzed retrospectively. Results The age at hysterectomy, the age at the discovery of pelvic mass, and the time interval between the occurrence of pelvic mass and hysterectomy in the malignant tumor group were higher than those in the benign tumor group, with statistical significance (P<0.05). In the malignant tumor group, 73.9% of the patients had abdominal pain, abdominal distension, vaginal bleeding or drainage and other clinical symptoms, while only 26.1% of the patients were found during physical examination, and the difference was statistically significant compared with the benign disease group (P<0.05). The ultrasound images of all patients in the malignant tumor group showed solid or cystic solid pelvic masses with large volume, accompanied by increased tumor markers of different degrees, and the difference was statistically significant compared with the benign tumor group (P<0.05). Conclusions Malignant tumors are more likely to occur in older patients with hysterectomy with interval of more than 5 years, and most patients have clinical symptoms. Once pelvic masses are found in such patients, comprehensive analysis should be carried out in combination with the imaging characteristics of the tumor, the level of serum tumor markers, and the symptoms of the patients, and early surgical treatment should be performed to avoid the delay of the disease.

Key words： hysterectomy pelvic mass malignant tumor

Received: 10 May 2023

ZTFLH:

R713.42

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	CHEN Fang
	ZHANG Ying
	GUO Yinshu

Cite this article:

CHEN Fang,ZHANG Ying,GUO Yinshu. Clinical characteristics of malignant pelvic tumors after hysterectomy for benign lesions[J]. Med. J. Chin. Peop. Armed Poli. Forc., 2023, 34(11): 945-948.

URL:

http://journal08.magtechjournal.com/Jwk_wjyx/EN/ OR http://journal08.magtechjournal.com/Jwk_wjyx/EN/Y2023/V34/I11/945

[1]	Society of Gynecologic Oncology.SGO Clinical practice statement:salpingectomy for ovarian cancer prevention.Chicago(IL):SGO2013[EB/OL].[2023-02-23].https://www.sgo.org/clinical-practice/guidelines/sgo-clinical-practice-statement-salpingectomy-forovarian-cancer-prevention/.
[2]	Holub Z,Jandourek M,Jabor A,et al.Does hysterectomy without salpingo-oophorectomy influence the reoperation rate for adnexal pathology? A retrospective study[J]. Clin Exp Obstet Gynecol,2000,27(2):109-112.
[3]	Pynnä K, Vuorela P, LodeniusL, et al.Cost-effectiveness of hysterectomy for benign gynecological conditions: a systematic review[J]. Acta Obstet Gynecol Scand, 2014, 93(3):225-232.
[4]	Evans E C,Matteson K A,Orejuela F J,et al.Society of Gynecologic Surgeons Systematic Review Group. Salpingo-oophorectomy at the time of benign hysterectomy: a systematic review[J].Obstet Gynecol,2016, 128(3):476-485.
[5]	Naz F, Begum A.Experience with pelvic masses following hysterectomyfor benign disease[J]. Biomedica,2004, 20:106-109.
[6]	Meng B,Xu M.Pelvicartificial isolation with ultrasound-guided fluid: a new technique in ovarian endometriotic cyst transabdominal sclerotherapy[J]. Med Sci Monit, 2022, 28:e937855.
[7]	Chao X,Wang X,Xiao Y,et al.Clinical analysis of high risk factors for pelvic malignant tumors after hysterectomy for benign diseases[J].Medicine (Baltimore), 2019, 98(41):e17540.
[8]	Ducie J,Dao F,Considine M,et al. Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma[J]. Nat Commun,2017, 8(1):990.
[9]	方玉婷,童焰,王玉,等.子宫切除术中行预防性双侧输卵管切除对卵巢功能的影响[J].中国妇产科临床杂志,2017,18(5):473-475.
[10]	Salvador S,Scott S,Francis J A, et al. No. 344-opportunistic salpingectomy and other methods of risk-reduction for ovarian/fallopian tube/peritoneal cancer in the general population[J].J Obstet Gynaecol Can,2017,39(6):480-493.
[11]	Kim M,Kim Y H,Kim Y B,et al.Bilateral salpingectomy to reduce the risk of ovarian/fallopian/peritoneal cancer in women at average risk:a position statement of the Korean Society of Obstetrics and Gynecology(KSOG)[J].Obstet Gynecol Sci,2018,61(5): 542-552.
[12]	ACOG.ACOG committee opinion No.774: opportunistic salpingectomy as a strategy for epithelial ovarian cancer prevention[J].Obstet Gynecol, 2019, 133(4): e279-e284.
[13]	陈芳,张颖.子宫切除术后不同病理类型盆腔包块56例临床特点及诊疗分析[J].中国妇产科临床杂志,2022,23(1):35-37.
[14]	Meys E M, Kaijser J, Kruitwagen R F,et al.Subjective assessment versus ultrasound models to diagnose ovarian cancer: a systematic review and meta-analysis[J].Eur J Cancer,2016,58:17-29.
[15]	胡昌锋,邬玉,张良成.彩色多普勒超声评分系统在卵巢良恶性肿块鉴别诊断中的应用[J].海南医学,2019,30(9):1170-1173.
[16]	赵姝娟,张光华,周晓光,等.上皮性卵巢癌患者CT、MRI影像学特征及与血清标志物CEA、CA199、CA125水平的相关性研究[J].现代生物医学进展,2022,22(4):775-780.
[17]	李鸿玉,孙立新.影像学检查及血清糖类抗原125、人附睾蛋白4用于卵巢上皮性癌与盆腔结核鉴别诊断及预后评估的研究进展[J].肿瘤研究与临床,2021,33(6):473-476.

[1]	. [J]. Med. J. Chin. Peop. Armed Poli. Forc., 2021, 32(11): 1006-1010.